Abbott India Q1 net up 71% to Rs 51 cr

Tags: Companies
Drug firm Abbott India today posted 71.42 per cent rise in its net profit to Rs 50.93 crore for the first quarter ended June 30.

The company had posted a net profit of Rs 29.71 crore for the same period of previous fiscal.

Net sales of the company rose to Rs 516.91 crore for the first quarter, as compared to Rs 429.68 crore during the same period of previous fiscal, Abbott India Ltd said in a filing to the BSE.

In 2010, Abbott acquired both the pharmaceutical business of Solvay, which had a presence in India, and Piramal Healthcare Solutions, which was part of Piramal Group.

These transactions made it one of the largest health care companies in the country. It now employs about 14,000 people in India, making it the firm's largest employee base outside the US.

Shares of Abbott India were trading at Rs 2,330 apiece on the BSE, up 7.08 per cent from its previous close.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Media obsession with his layoff smacks of lack of focus

    Pretty much like his abrupt vanishing act had done 50-odd days ago, Congress vice president Rahul Gandhi’s return on Thursday from a long and myster

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

Sarthak Raychaudhuri

vice-president, HR, Asia South Whirlpool of India

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

TODAY'S COLUMNS

Varun Dutt

<b>Riskfactor</b>: Oblivious to reality

The hostile media effect, originally deemed the hostile media phenomenon, ...

Zehra Naqvi

Sensual wordplay

The student of literature looks for form and structure. The ...

Bubbles Sabharwal

The bitter cold heart of life

Life has a heart just as we do. Most times ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture